Integra Lifesciences Holdings (IART) Restructuring Costs (2011 - 2012)
Integra Lifesciences Holdings' (IART) quarterly Restructuring Costs came in at $49.3 million in Q2 2012, down 10.75% year-over-year from $55.2 million in Q3 2011, and up 5.56% quarter-over-quarter from $46.7 million in Q1 2012.
Powered by 
Analysis
Integra Lifesciences Holdings (IART) Restructuring Costs (2011 - 2012) Analysis & Trends
Integra Lifesciences Holdings has disclosed Restructuring Costs across 2 years of filings, most recently posting $49.3 million for Q2 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Integra Lifesciences Holdings | 1.25 Bn | 977.26 Mn | 219.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2012 | 49.27 Mn |
| Mar 31, 2012 | 46.68 Mn |
| Jun 30, 2011 | 55.20 Mn |
| Mar 31, 2011 | 39.39 Mn |